We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I wouldn't bank on 9p holding, could fall further depending on sentiment. Equally it could be they'll pump it up with news flow once Diggle and co are allocated their shares from April, to give him option to dump again if price gets high enough. Beyond that the biggest overhang is lack of revenue. Despite all the bluster they're still a long way from being self-sufficient and cash burn remains high, so only a matter of time before the begging bowl comes out again.
Taverham
Until Oxford get this validated and into mainstream target instead of private companies. They are going to struggle.
This fund raise will only get them to Xmas
They need to be ramping up sales now otherwise they will defo need another fund raise by the end of the year
That’s a fact
So in a nutshell this will barely move of 9p till April? As any buys now will be at this level, no one buying it higher?
Kong, thanks that is only 0.2% of the market , i.e only 1 in 50 for the most accurate test in the world?
Taverman
It’s a 1000 tests per month not 100 and Oxford said they’d like to achieve it by the end of the year
That’s 34 tests per day compared to just 2 now !!
....are, in fact, buys, 100%
Dusty - I have decided that I've invested enough and will not chase this further. If this does realise a small percentage of its potential I'll be more than quids in, even at my current break even level.
What will be very interesting is how much new money the bods will be adding.
Just rerad a comment on here that they are actually targetting 100 tests per month, not day and assuming that is correct it is only 0.2% of current psa tests . The company needs a real challenge on this imv.
I would say not to expect share price recovery any time soon. Momentum is killed by market knowing there are an enormous amount of 9p shares hitting the market in April. Inevitably a good proportion of those will be sellers of anything above 9p, whether existing holders now to arbitrage future shares due, or new holders come April.
What can we expect moving forward from here? Sp is at its lowest I've seen, I have the funds to bring my average down massively in a route to clear losses at a good speed, but I'm hesitant as to its direction, should I invest more to bring average lower? so I write this one off? Do I wait patiently for more news? I'm not in the habit of asking advice on how to manage investments but we can all agree we got stung pretty bad here, and was led down the garden path and are quite in the dark on its direction at this point, even just what people's general idea on which way there heading be helpful, this one's been a disaster
I can’t help but think if this was America. They would have taken this tech and raised 100 mio dollars . Price would not matter . Build a moat/ manufacturing/ PR/ sales . Beg steal borrow to get on this prostrate national test and get the bloody thing verified . A big pharma would swoop on this and pay billions if it was set up right and s good as they say it is( who knows ).
I’ve been actually hammered this year . Avacta, these idiots and shield . Stupid stupid me . I was out at 15 pence and will only come back if they get on this nhs screening test . Trouble is I think they get bullied by
Initial big holders that are scared of dilution . Needs to done with at least 2/3 years cash run way so everyone’s not running around panicking about share price / future raises than getting the job done . I hope This works fr the many grumpy old men like me that have no way of telling if they have prostrate cancer or not .Why only raise 10 now . It be was bloody 40 pence a few weeks ago and they knew they were selling bigger all
Hi Dugwalker
I have to agree with you 100%
They are only targeting private companies like Bupa etc.
Their product needs to be validated otherwise they cant sell to the mases, IE goverment funded organistions like the NHS.
Until this happens, Burrows and his "hand" picked team will fumble from day to day.
I notice on linkedin, all their posts are only liked by a handful of Oxfords employees.
Its a total joke. there will be another fund raise around november time as this money will only last until the end of the year.
Significant numbers of tests need to be selling now to stave off the next funding, But selling only 2 per day isnt going stop this.
Oxford have been selling circa 2 per day of both tests since december.. The new sales guy employed in december has not effected sales so far to date, with the numbers given to us.
I also note, when we got an RNS on the 17th of janurary, we got the number of sales up to the day before.
This last RNS we only got the sales figures up to the 9th of feburary, which was over a month ago. !!!!
Has sales dropped off this last month ?
Or has sales increased quite a bit so the board can notify us shortly, thus giving the institutional investors a door to get out and make some money for their gratitude of keeping the lights on for Oxford.
Call me cynical if you want but no doubt time will tell. !!!
Kong
..think you'll find the target is 1,000 per month not per day...."The PSE vertical is led by Dr Steve Arrivo, who joined the Company in November 2023 as Senior Vice President of Business and Corporate Development. Through the remainder of 2024 and beyond, the Company's commercial team will have a focus on large accounts, particularly including concierge medicine cash-pay customers, as the quickest way both to increase sales volumes and positively impact cash flow (the test has a price of $950 and the team is seeking to increase orders to a level of 1,000 tests per month). In addition, the Company will seek national distribution partners to make the test more readily accessible across the whole of the US and utilise available capacity at the Company's CLIA-registered lab."
Let's hope so.... 01234
Wasn’t sure I what it was. Good chance of some sort of recovery from here
333,000 £30.94k....buy
Hi Tav,
Your analysis of the numbers of sales from national screening programme are spot on. My fear is that missing out on Transform will highlight the scale of the missed opportunity to many that are still taken in by the spin from Burrows. It will also bring the incompetence and ineptitude of the BoD into sharp focus.
If I am right in my suspicion that sales are stalled by the lack of clinical validation then they will miss the quickest, largest and most cost effective way to attain that validation and sales will continue at insignificant levels for the foreseeable future. OBD certainly cannot afford to finance their own randomised control study at a scale that would convince the relevant regulatory bodies. In my opinion the market will respond appropriately and it won't be a positive response.
Dug, If we are not in the trial I do not think it will be a blood bath because our sales efforts [laughable though they are] seem to be in the USA and just now our sp assumes only small volumes. What I see as the real crime is the assumption that we wont be in the Transform project. Predictions of 1000 sales per day means around 200 in uk and 800 in usa. That is about as many needed in each small town it is a pathetic ambition. The transform project must be assuming thousands per day. There are 1 million ish psa tests per annum in UK , 3000 per day and we are aiming for 6% of that . Does that need any sales people??
I disagree with this thread. If you look back at Director deals you will see that Diggle has pumped millions into this company at prices as high as 67p. Addmittedly his last sells and subsequent buys have been to his advantage but he has just pumped another £200k into the company. Can you imagine what you would say to our CEO, if your stake had fallen by £5m in the last few weeks? And then be asked for yet more cash. I think he is the best hope for investors as he has so much skin in the game and he has a great track record.
Happy to risk a punt at 9.3p today and then wait and see how 2024 unfolds for OBD.
Didn’t think so
Here’s a weird off topic observation. What was the last speeding ticket rns anyone has seen? Does anyone actually invest in aim companies any more?
Apart from treating private investors with contempt, they must also think we are stupid and unable to remember what was said. "Word of mouth was going to sell CiRT" Because medical professionals have heard it all before from sales people.
@Krull.
Our CEO seems to be economic with the truth habitually.
In the case of the critical sales person and his belief that this was a credible explanation for declining sales, he may just have demonstrated that he is too dumb to walk upright.
Should say repeat